Filters

Found 1 Question

Set Default

NEET (PG)

2001

Pharmacology

Anti-tubercular Drugs - Dose Adjustment in Renal Failure
ACE inhibitors and renin-angiotensin system
Adrenal steroid inhibitors
Adverse Drug Reactions
Allopurinol - Indications in Gout
Amphotericin B liposomal formulation
Amphotericin B toxicity
Anthelmintic Drugs - Albendazole
Anti-Pseudomonal Antibiotics
Anti-estrogens and SERDs
Anti-glaucoma drugs - beta blockers
Anti-gout drugs - colchicine mechanism
Anti-osteoporotic drugs - Bisphosphonates
Antiarrhythmic drugs
Antiarrhythmics / QT prolongation
Antibiotic Mechanisms of Action
Antibiotics - bacteriostatic vs bactericidal
Anticancer Drug Toxicity - Cardiomyopathy
Anticancer Drugs
Anticholinergic effects and drug substitution in elderly
Anticoagulants
Anticoagulants (direct oral anticoagulants)
Anticoagulants (oral factor Xa inhibitors)
Antiemetic drugs
Antiemetics - 5-HT3 antagonists
Antiepileptic teratogenicity
Antifungal agents
Antifungal drugs
Antigout drugs
Antihistaminics (H1 blockers)
Antihypertensives in CKD
Antimicrobial selection / Resistance
Antimicrobials - antibiotic sources
Antimicrobials / Mycoplasma
Antimuscarinic drugs / Peptic ulcer therapy
Antiparkinsonian drugs - COMT inhibitors
Antiplatelet drugs - prasugrel
Antiprogestins
Antiprotozoal therapy - coccidia
Antipsychotic side effects
Antirheumatic drugs
Antitubercular drugs
Anxiolytics and serotonin receptors
Autacoids and their Antagonists
Autonomic Pharmacology and CNS Drugs
Beta-Blockers - Propranolol Indications and Contraindications
Beta-lactam resistance
CNS pharmacology - GABA-A receptor ligands
Caffeine — adenosine receptor antagonism
Cardiac glycosides and digitalis toxicity
Cardiovascular system
Central Nervous system
Cephalosporins - adverse effects
Chemotherapy
Chemotherapy Induced Pulmonary Toxicity
Chloramphenicol Grey Baby Syndrome
Cholinergic drugs
Co-trimoxazole - G6PD Deficiency and Clinical Uses
Copper chelators in Wilson disease
Corticosteroids - hydrocortisone replacement dose
DMARDs in rheumatoid arthritis
Digoxin toxicity arrhythmias
Diuretics
Diuretics (site of action)
Diuretics and antihypertensives
Dose-response curve
Drug Interactions - Rifampin and Protease Inhibitors
Drug induced myopathy
Drug interactions
Drug interactions - disulfiram-like reaction
Drug metabolism - cytochrome P450
Drug safety in pregnancy
Drug therapy
Drug-induced hyperuricemia / gout
Drugs for benign prostatic hyperplasia
Emergency contraception
Endocannabinoids / neurotransmitters
Fluoroquinolones
G6PD Deficiency - Oxidant Drug Triggers
GLP-2 analog - short bowel syndrome
Gastrointestinal system
General Pharmacology
Gout and NSAIDs
H. pylori eradication
Heart failure drugs (ARNI)
Hematopoietic growth factors
Hormonal contraception - Progestin-only pills
Hormones
Hypolipidemic drugs (bile acid sequestrants)
Imatinib for GIST
Immunomodulators
Injectable hormonal contraceptives
Inotropes and PDE-3 inhibitors
Insulin therapy in diabetes
Lapatinib dual HER1/HER2 inhibitor
Laxatives - anthranoid stimulants
Lepirudin for HIT
Leukotriene Inhibitors - Asthma Pharmacology
Linezolid toxicity monitoring
Lithium
Lithium - teratogenic cardiac effects
Lithium drug interactions
Lithium toxicity
Local Anaesthetics
Methotrexate urinary alkalinization
Methylxanthines
Migraine prophylaxis drugs
Movement disorders - chorea management
Mycophenolate mofetil adverse effects
NK1 antagonist antiemetics
NRTI adverse effects (didanosine)
Neuromuscular blocking agents
Nitric oxide signalling
Non-hormonal therapy for hot flushes
Opioid analgesics in day-care surgery
Opioid tolerance
Oral Hypoglycemic Agents - Mechanism of Action
Oral antidiabetics (biguanides)
Osteoporosis drugs - antiresorptive vs anabolic
Ototoxicity - aminoglycosides
PDE-5 inhibitors - nitrate interaction
Pharmacokinetics
Pharmacokinetics - drug ionisation and Henderson-Hasselbalch
Pharmacokinetics - plasma protein binding
Pharmacology of cardiovascular system
Pharmacology of central nervous System
Posterior pituitary drugs - desmopressin
Potassium channel openers (antianginals)
Preterm labour and antenatal corticosteroids
Prokinetic drugs
Prostaglandins in obstetrics
Pulmonary Vasodilators
Pulmonary arterial hypertension drugs
Receptor pharmacology
Restless leg syndrome
Resuscitation - vasopressors
Serotonin syndrome management
Smoking cessation agents
Sulphonamides classification
Teratogenic drugs - antiepileptics in pregnancy
Theophylline mechanism of action
Therapeutic index
Topical corticosteroid vehicles and potency
Toxicology - Heavy Metal Poisoning
Toxicology and Antidotes
Tyrosine kinase inhibitors
Uterotonics in postpartum hemorrhage
Vasopressin analogues
Warfarin Overdose - Reversal Therapy

List of top Pharmacology Questions on Anti-tubercular Drugs - Dose Adjustment in Renal Failure asked in NEET (PG)

A patient with hypertension has a serum urea of 55 mg/dL and serum creatinine of 5.6 mg/dL, indicating renal failure. Which of the following anti-tubercular drugs does NOT require the dose to be reduced in this patient?